Tristel plc (AIM:TSTL)

Market Cap	183.10M -7.5%
Revenue (ttm)	49.54M +13.7%
Net Income	7.86M +28.1%
EPS	0.16 +26.1%
Shares Out	47.93M
PE Ratio	23.52
Forward PE	22.06
Dividend	0.14 (3.72%)
Ex-Dividend Date	Mar 19, 2026

Volume	60,313
Open	379.00
Previous Close	382.00
Day's Range	370.00 - 383.50
52-Week Range	340.00 - 445.00
Beta	0.34
Analysts	Strong Buy
Price Target	472.33 (+24.3%)
Earnings Date	Jun 1, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 270
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.